GC Biopharma's US Laredo Plasma Center Obtains FDA Approval
GC Biopharma announced on the 9th that its US subsidiary ABO Plasma's Laredo plasma center in Texas has obtained FDA approval, enhancing the stability of its raw plasma supply chain.
Key takeaway
"GC Biopharma's US Laredo Plasma Center Obtains FDA Approval" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 10 out of 100. GC Biopharma announced on the 9th that its US subsidiary ABO Plasma's Laredo plasma center in Texas has obtained FDA approval, enhancing the stability of its raw plasma supply chain. Reported by Maeil Business on April 09, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 53.2%.
